These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18216524)

  • 21. Axillary vs sentinel lymph node dissection for invasive breast cancer.
    Vuthaluru S; Srivastava A
    JAMA; 2011 Jun; 305(22):2290; author reply 2290-1. PubMed ID: 21642675
    [No Abstract]   [Full Text] [Related]  

  • 22. Sentinel-node biopsy in breast cancer.
    Munster AM
    N Engl J Med; 2003 Nov; 349(20):1968-71; author reply 1968-71. PubMed ID: 14626251
    [No Abstract]   [Full Text] [Related]  

  • 23. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
    Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
    Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgeon-initiated and -managed randomized controlled trial to evaluate axillary sentinel node surgery in breast cancer.
    Malycha P
    ANZ J Surg; 2005 Mar; 75(3):94. PubMed ID: 15777379
    [No Abstract]   [Full Text] [Related]  

  • 25. Implications of a postoperative rehabilitation program on quality of life in women with primary breast cancer treated with sentinel lymph node biopsy or complete axillary lymph node dissection.
    Pinto e Silva MP; Sarian LO; Morais SS; Pace do Amaral MT; Freire de Oliveira MM; Derchain S
    Ann Surg Oncol; 2008 Dec; 15(12):3342-9. PubMed ID: 18931880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sentinel lymph node biopsy with predict factors to omit axillary lymph node dissection].
    Suzuki TH; Nagashima T; Sakakibara M; Fujimoto H; Miyazaki M
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():360-4. PubMed ID: 23350421
    [No Abstract]   [Full Text] [Related]  

  • 27. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
    Gauthier T; Fermeaux V; Mollard J; Aubard Y
    Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer.
    Takei H; Kurosumi M; Yoshida T; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Asakawa H; Oba H; Inoue K; Tabei T
    Breast; 2009 Aug; 18(4):244-7. PubMed ID: 19559610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreasing arm morbidity by refining axillary surgery in breast cancer.
    Ponzone R; Cassina E; Tomasi Cont N; Biglia N; Sismondi P
    Eur J Surg Oncol; 2009 Apr; 35(4):335-8. PubMed ID: 18715747
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advances in sentinel lymph node biopsy for breast cancer.
    Goyal A; Mansel RE
    Curr Opin Oncol; 2008 Nov; 20(6):621-6. PubMed ID: 18841040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is axillary dissection unnecessary in patients with a positive sentinel lymph node?
    Noguchi M
    Breast Cancer; 2012 Oct; 19(4):279-81. PubMed ID: 22528803
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
    Samphao S; Eremin JM; El-Sheemy M; Eremin O
    Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation in the RACS sentinel node biopsy versus axillary clearance trial.
    Wetzig NR; Gill PG; Ung O; Collins J; Kollias J; Gillett D; Gebski V; Greig C; Ray A; Stockler M;
    ANZ J Surg; 2005 Mar; 75(3):98-100. PubMed ID: 15777382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micrometastasis and axillary dissection in breast cancer.
    Badruddoja M
    Arch Surg; 2010 Oct; 145(10):1022-3; author reply 1023. PubMed ID: 20956777
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimal Management of the Axilla: A Look at the Evidence.
    Mamounas ET
    Adv Surg; 2016 Sep; 50(1):29-40. PubMed ID: 27520860
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of the axilla after the finding of a positive sentinel lymph node: a proposal for an evidence-based risk-adapted algorithm.
    Evans SB; Gass J; Wazer DE
    Am J Clin Oncol; 2008 Jun; 31(3):293-9. PubMed ID: 18525310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical management of the axilla: do intramammary nodes matter?
    Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.